Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01769885
Previous Study | Return to List | Next Study

Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer

This study has been withdrawn prior to enrollment.
National Cancer Institute (NCI)
AVEO Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Roswell Park Cancer Institute Identifier:
First received: January 15, 2013
Last updated: December 17, 2013
Last verified: December 2013
No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)